Dr Wood's primary research interests lie in the use of gene therapy to treat rare inherited disorders. Currently he's based in the Stem Cell and Neurotherapies laboratory, at the University of Manchester, researching treatments for a form of inherited metabolic disease. He also has an interest in using gene therapy to treat inherited retinal disorders.

BSc (Honours) Genetics with Industrial Experience - University of Manchester 2012

MRes Translational Medicine: Interdisciplinary Molecular Medicine - University of Manchester 2013

DPhil Clinical Neuroscience - Oxford University 2017

Gene Therapy

Molecular Biology Techniques

Production and Characterisation of AAV and Lentiviral Vectors

Histology and Confocal Microscopy

Protein and Gene Expression Assays

Dr Wood graduated from The University of Manchester in 2012 with a BSc (Honours) in Genetics with Industrial Experience and in 2013 with a MRes in Translational Medicine. He then undertook his DPhil in Clinical Neuroscience at Oxford University, under the supervision of Professor Robert Maclaren. His doctoral research focused on using recombinant adeno-associated virus (AAV) vectors in a gene therapy strategy to treat autosomal recessive bestrophinopathy (ARB), an inherited retinal degeneration. Dr Wood is now based in the Stem Cell and Neurotherapies group at the University of Manchester, working with Professor Brian Bigger, where his research focusses on producing gene therapy treatments for neurological lysosomal storage disorders. 

British Society of Gene and Cell Therapy (BSGCT)